By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Regulus Therapeutics today announced it is collaborating with researchers at the University of California, San Diego School of Medicine to develop treatments for angiogenic disease using microRNA therapeutics.

The collaboration combines Regulus' miRNA platform with UCSD's expertise in animal models of angiogenesis. The collaboration recently received a UC Discovery Grant that promotes work between the university's researchers and industry.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.